.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
McKinsey
Covington
Accenture
Cerilliant
Mallinckrodt
Healthtrust
Colorcon
AstraZeneca
Moodys

Generated: July 22, 2017

DrugPatentWatch Database Preview

Organon Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?

ORGANON USA INC has thirty-four approved drugs.

There are seven US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.

There are one hundred and fifty-six patent family members on ORGANON USA INC drugs in forty countries.

Summary for Applicant: Organon Usa Inc

Patents:7
Tradenames:34
Ingredients:29
NDAs:34
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
FOLLISTIM AQ
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021211-003Feb 11, 2004DISCNNoNo7,563,763► Subscribe ► Subscribe
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006DISCNNoNo► Subscribe► Subscribe
Organon Usa Inc
RAPLON
rapacuronium bromide
INJECTABLE;INJECTION020984-001Aug 18, 1999DISCNNoNo► Subscribe► Subscribe
Organon Usa Inc
REVERSOL
edrophonium chloride
INJECTABLE;INJECTION089624-001May 13, 1988DISCNNoNo► Subscribe► Subscribe
Organon Usa Inc
LIQUAEMIN SODIUM
heparin sodium
INJECTABLE;INJECTION000552-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
REMERON
mirtazapine
TABLET;ORAL020415-003Mar 17, 19975,977,099► Subscribe
Organon Usa Inc
ZEMURON
rocuronium bromide
INJECTABLE;INJECTION020214-003Mar 17, 19944,894,369*PED► Subscribe
Organon Usa Inc
CALDEROL
calcifediol
CAPSULE;ORAL018312-001Approved Prior to Jan 1, 19823,833,622► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-003Jan 12, 20015,178,878► Subscribe
Organon Usa Inc
REMERON SOLTAB
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL021208-003Jan 12, 20015,977,099► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ORGANON USA INC drugs

Drugname Dosage Strength Tradename Submissiondate
ethinyl estradiol and etonogestrel
Vaginal Ring0.015 mg/24 hour and 0.12 mg/24 hour
NUVARING
6/17/2013
ganirelix acetate
Injection250 mcg/0.5 mL, 1 mL PFS
GANIRELIX ACETATE
3/30/2012

International Patent Family for Organon Usa Inc Drugs

Country Document Number Estimated Expiration
BrazilPI0508865► Subscribe
Denmark0974359► Subscribe
Norway980177► Subscribe
Russian Federation2007132007► Subscribe
Hong Kong1026615► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Organon Usa Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
80027Netherlands► SubscribePRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
156Luxembourg► SubscribePRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
6Finland► Subscribe
2010Austria► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Argus Health
Medtronic
Cipla
Express Scripts
Harvard Business School
Queensland Health
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot